气雾剂

qì wù jì
  • aerosol
气雾剂气雾剂
  1. 最近,该公司的投资组合中加入了杜克大学(DukeUniversity)一位教授开发的专利,涉及一项利用一种生产含有尼古丁气雾剂的独特方法的技术。

    Last week it added to its portfolio a patent developed by a Duke University professor for a technology employing a unique method for delivering a nicotine-containing aerosol .

  2. 方法制备了含抛射剂的两相INS气雾剂,并用HPLC方法测定其每揿剂量。

    METHODS Two phase INS aerosol in propellant system was prepared and the amount of insulin delivered per actuation was determined by HPLC method .

  3. 中药气雾剂技术呈现缓慢发展的状况,但不乏个别表现突出的品种

    A relatively slow developing trend was shown , however , good protrusive kinds of TCM aerosols not seldom .

  4. HPLC法测定复方利福平气雾剂中利福平及异烟肼含量

    HPLC Determination of Rifampicin and Isoniazid in Compound Rifampicin Aerosol

  5. 结论特布他林和沙丁胺醇气雾剂吸入治疗均能改善哮喘儿童的呼吸功能,其中以R5更为敏感。

    Conclusion Respiratory of asthma children can be unproved with the use of Terbutaline and Salbutamol aerosols inhalation which R5 was more sensitive .

  6. 丙卡特罗气雾剂的不良反应发生率为9.9%,对照药为11.7%(P0.05)。

    The adverse drug reaction rate of procaterol was 9.9 % and that of the controlled was 11.7 % ( P0.05 ) .

  7. SD大鼠腹腔注射卵蛋白制成哮喘模型,分别予相应方法治疗,并与必可酮气雾剂比较。

    SD rats were modeled into asthmatic rats by abdominal injection of egg albumin , and then treated by aforementioned methods ;

  8. 吸入激素组在常规治疗基础上,加用二丙酸倍氯米松(必可酮)气雾剂治疗,每天1000μg,连续治疗3个月;

    Group A ( 24 cases ) inhaled glucocorticosteroids ( Becotide ( 1 000 μ g · d ~ ( - 1 )) for three months ) on the base of routine therapy .

  9. 目的评价吸入必可酮气雾剂(BDP)对咳嗽变异型哮喘(CVA)的疗效。

    Objective To evaluate the effects of inhaled BDP in patients with CVA .

  10. 气雾剂推进剂贮配供应新技术HMX与燃烧催化剂共包覆降低NEPE推进剂的压力指数

    Lowering the Pressure Exponents of NEPE Propellant by Co coated HMX and Burning rate Catalysts

  11. 采用HPLC法测定了布地奈德气雾剂中布地奈德总量、每揿含量、有效部位药物沉积量及R-异构体的含量。

    A HPLC method for determination of the total content , the content per spout , the deposition ratio in the effective position and R - isomer in budesonide aerosol was presented .

  12. 大气气溶胶中NO ̄-_3、SO ̄(2-)_4研究对我国逐步淘汰医用气雾剂所用CFCs抛射剂的建议

    THE STUDIES OF AND IN AEROSOL Suggestion on Phasing out CFCs Propellants from Medical Aerosol in China

  13. HAPs油基杀虫气雾剂水分引起腐蚀及其控制研究

    Control of corrosion of HAPs oil-based insecticide aerosol which caused by moisture

  14. 20min采血药动学方法评价沙丁胺醇气雾剂的生物等效性

    Bioequivalent evaluation of two salbutamol aerosols by pharmacokinetic method sampling over 20 minutes

  15. 通过黄连气雾剂局部作用于口腔,清除口腔内的Hp,阻断幽门螺杆菌的体内再感染途径,以达到根治Hp的目的。

    Through clear away Hp in the oral cavity with Rhizoma Coptidis aerosol to chop broken the reinfection channel of Helicobacter Pylori in the body , in order to eradicating Hp in the body .

  16. 目的:比较溴化异丙托品(IPB)气雾剂与沙丁胺醇(SA)气雾剂分别使用及联合应用对哮喘和COPD患者的支扩作用。

    Objective : To compare the effect of ipratropium bromide ( IPB ) with sulbutamol ( SA ), on bronchodilatation in patients with asthma and COPD .

  17. 芪香气雾剂低、中、高剂量组肺指数均显著低于模型组(P0.01);与阳性对照组比较无明显差异(P0.05)。

    Lung index of " QiXiang " aerosol group was lower than that of flu model group ( P0.01 ); and had no distinct difference from the positive control group ( P0.05 ) . 3 .

  18. 目的:观察布地奈德气雾剂治疗小儿哮喘前后的最高呼气峰流速值(PEF)的变化。

    Objective : To observe the differences of peak expiratory flow ( PEF ) before and after budesonide aerosol inhalation for children 's asthma .

  19. 研究表明,长期吸入普米克气雾剂400~1000μg/日对肾上腺皮质功能、血细胞无明显影响,为一安全剂量。

    It indicate that there is no obvious influence for patients to inhale pulmicort 400 ~ 1 000 μ g each day over a long period of time and the amount of pulmicort is proved to be a safe dose for patients .

  20. 结论:国产复方硫酸沙丁胺醇气雾剂是治疗慢性阻塞性肺病(COPD)安全有效药物,其疗效和安全性与进口可必特气雾剂相似。

    Conclusion : Compound salbutamol sulfate aerosol is a safe and effective drug in the treatment of COPD , and the efficacy and safety of compound salbutamol sulfate aerosol is similar to that of Combivent .

  21. 建立了LC-MS/MS法测定大鼠血浆中沙丁胺醇浓度,并比较了两种沙丁胺醇气雾剂在大鼠体内的药动学行为。

    A LC-MS / MS method for determination of the concentration of salbutamol in rat plasma was established . In vivo pharmacokinetics of two brands of salbutamol aerosol in rats by pulmonary administration was investigated .

  22. 在经过16a的发展之后,中国已初步奠定了气雾剂工业的基础。

    Experienced 16 years development , Aerosol industry has solidly laid its foundation in China .

  23. 目的观察普米克气雾剂治疗儿童哮喘前后的最高呼气峰流速值(PEF)及血清嗜酸细胞阳离子蛋白(ECP)的变化。

    Objective To observe the differences of peak expiratory flow ( PEF ), and serum eosinophil cationic protein ( ECP ) before and after Pulmicort aerosol inhalation for childhood asthma .

  24. 结果:吸入可必特气雾剂在15,30minFEV1的改善情况高于单吸溴化异丙托品气雾剂(P<0.01);

    Our results showed that improvement in FEV 1 15 and 30 min after inhalation of Combivent was greater than those after inhalation of Atrovent ( P < 0.01 );

  25. 连续给药7d,丙卡特罗气雾剂的临床疗效为88.5%,肺功能疗效为77.0%,均优于对照药(P<0.05);

    The clinical and lung function efficacy of 7 days duration were 88.5 % and 77.0 % respectively which were superior compared with those of salbutamol ( P < 0.05 ) .

  26. 结论各级临床医师对哮喘基础知识、临床用药、GINA方案的应用、峰流速仪及气雾剂的掌握情况均较6年前有明显改善。

    ConclusionThe basic knowledge about asthma , selection of medication , implementation of GINA and the use of peak expiratory flow meter have been greatly improved than those of6 years ago .

  27. MaryanneVenables表示:“没有我的灰色小朋友,喘乐宁气雾剂,我哪儿都不能去。”

    Maryanne Venables said ," I can 't go anywhere without my little gray friend , my little Ventolin inhaler . "

  28. 1977年至1995年我科应用丙酸倍氯松气雾剂(BDP)防治小儿哮喘千余名,平均剂量为300μg·d,疗程2.16±1.52年。

    Inhaled Beclomethasone Dipropionate ( BDP ) were administered in 399 children with asthma during 1977 to 1995 at the average dosage of 300 μ g / d and the duration of 2 . 16 ± 1 . 52 years .

  29. 目的:评价国产丙卡特罗气雾剂(procaterol)与沙丁胺醇气雾剂随机对照治疗轻中度哮喘的疗效和安全性。

    OBJECTIVE : To evaluate the efficacy and safety of procaterol aerosol inhaler compared with salbutamol aerosol inhaler in mild and moderate bronchial asthma treatment .

  30. 本文简要介绍了我国医用气雾剂的分类组成,国外已用于医用气雾剂的各种CFCs替代品、替代技术和装置,并对我国启动替代进程提出五点建议。

    This paper introduced briefly the classification of China medical aerosols , the alternative substances technologies and devices that replace CFCs from medical aerosols abroad , finally 5 suggestions be raised for starting phasing out process .